의료용 영상 시장 규모, 점유율, 동향 분석 보고서 : 기술별, 용도별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Medical Imaging Market Summary

The global medical imaging market size was valued at USD 43.5 billion in 2025 and is projected to reach USD 64.7 billion by 2033, growing at a CAGR of 5.1% from 2026 to 2033. The increasing prevalence of chronic diseases, surging demand for early disease diagnosis and detection tools, growing geriatric population, rising investments by key players, product innovations, and technological advancements such as integration of artificial intelligence (AI) in medical imaging, and development of point-of-care medical imaging equipment are expected to drive market growth during the forecast period.

The growing geriatric population is significantly influencing the growth of the medical imaging market as aging is associated with an increased risk of chronic diseases such as heart disease, stroke, cancer, and osteoporosis, among others, which often require diagnostic imaging for accurate diagnosis and management. The United Nations Population Division anticipates that the population of individuals aged 65 and above will double in the next 30 years, hitting a total of 1.6 billion by 2050.

The following charts illustrate that the world is heading toward an aging population. Japan has the highest share of elderly population, followed by Italy, Germany, France, and Denmark will have the highest proportions of elderly population in 2022. This is due to significant improvements in life expectancy over recent years, a trend that is expected to continue. By the year 2050, approximately 40% of the population in Hong Kong, South Korea, and Japan will be 65 or older. This marks a substantial increase from the current percentages in highly developed regions, where only about 20% of the population falls into this age group.

The rise in life expectancy globally is a critical driver for expanding the medical imaging market. As people live longer, they become more susceptible to chronic diseases. Medical imaging plays a pivotal role in accurately diagnosing, managing, and treating these diseases, offering detailed views of the body's internal state without invasive procedures. Therefore, as the global population ages, the demand for diagnostic imaging services is expected to surge, propelling the growth of the medical imaging market. This trend underscores the importance of advanced imaging technologies in meeting the healthcare needs of an increasingly aging population. According to the United Nations, a newborn in 2021 is projected to have an average lifespan of nearly 25 years longer than someone born in 1950, achieving an average age of 71 years, with females typically living five years longer than males.

Global Medical Imaging Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country level and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global medical imaging market report on the basis of technology, applications, end-use, and region:

• Technology Outlook (Revenue, USD Million, 2021 - 2033)
• X-ray Devices
  • Radiography
  • Fluoroscopy
  • Mammography
• Ultrasound
  • Handheld
  • Compact
  • Cart/Trolley Based
• Computed Tomography
  • High end slice CT
  • Mid end slice CT
  • Low end slice CT
  • Cone beam CT
• Magnetic Resonance Imaging
  • Closed System
  • Open System
• Nuclear Imaging
  • SPECT
  • PET
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Cardiology
• Oncology
• Neurology
• Orthopedics
• Gastroenterology
• Gynecology
• Other Applications
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Diagnostics Imaging Centers
• Others
• Region Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Technology
  • 1.2.2. Application
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Technology outlook
  • 2.2.2. Application outlook
  • 2.2.3. End Use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Medical Imaging Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing prevalence of cancer and cardiac diseases
    • 3.2.1.2. Favorable government initiatives
    • 3.2.1.3. Trends of preventive healthcare and disease screening programs
    • 3.2.1.4. Strategic collaborations
    • 3.2.1.5. Technological advancements
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of medical imaging equipment
    • 3.2.2.2. Increasing use of refurbished products
    • 3.2.2.3. Lack of regulations in developing countries
    • 3.2.2.4. Lack of trained radiologists
• 3.3. Medical Imaging Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Medical Imaging Market: Technology Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Medical Imaging Market: Technology Movement Analysis
• 4.3. Medical Imaging Market by Technology Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 4.5. X-ray Devices
  • 4.5.1. X-ray Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.1.1. Radiography
      • 4.5.1.1.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
    • 4.5.1.2. Fluoroscopy
      • 4.5.1.2.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
    • 4.5.1.3. Mammography
      • 4.5.1.3.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
• 4.6. Ultrasound
  • 4.6.1. Ultrasound Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.1.1. Handheld
      • 4.6.1.1.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
    • 4.6.1.2. Compact
      • 4.6.1.2.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
    • 4.6.1.3. Cart/trolley
      • 4.6.1.3.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
• 4.7. Computed Tomography
  • 4.7.1. Computed Tomography Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.1.1. High end slice CT
      • 4.7.1.1.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
    • 4.7.1.2. Mid end slice CT
      • 4.7.1.2.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
    • 4.7.1.3. Low end slice CT
      • 4.7.1.3.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
    • 4.7.1.4. Cone beam CT
      • 4.7.1.4.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
• 4.8. Magnetic Resonance Imaging
  • 4.8.1. Magnetic Resonance Imaging Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.8.1.1. Closed System
      • 4.8.1.1.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
    • 4.8.1.2. Open System
      • 4.8.1.2.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
• 4.9. Nuclear Imaging
  • 4.9.1. Nuclear Imaging Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.9.1.1. SPECT
      • 4.9.1.1.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
    • 4.9.1.2. PET
      • 4.9.1.2.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)

Chapter 5. Medical Imaging Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Medical Imaging Market: Application Movement Analysis
• 5.3. Medical Imaging Market by Application Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 5.5. Cardiology
  • 5.5.1. Cardiology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Oncology
  • 5.6.1. Oncology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Neurology
  • 5.7.1. Neurology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Orthopedics
  • 5.8.1. Orthopedics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.9. Gastroenterology
  • 5.9.1. Gastroenterology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.10. Gynecology
  • 5.10.1. Gynecology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.11. Other Applications
  • 5.11.1. Other Applications Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Medical Imaging Market: End-use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Medical Imaging Market: End-use Movement Analysis
• 6.3. Medical Imaging Market by End-use Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 6.5. Hospitals
  • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Diagnostic Imaging Centers
  • 6.6.1. Diagnostic Imaging Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Medical Imaging Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Medical Imaging Market movement analysis
• 7.3. Medical Imaging Market: Regional Estimates & Trend Analysis by Technology & End-use
• 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 7.5. North America
  • 7.5.1. North America Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. U.S. Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Canada Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Europe
  • 7.6.1. Europe Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. UK
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. UK Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. Germany Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. France Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. Italy Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Spain Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.7. Denmark
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Denmark Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Key Country Dynamics
    • 7.6.8.2. Competitive Scenario
    • 7.6.8.3. Regulatory Framework
    • 7.6.8.4. Reimbursement scenario
    • 7.6.8.5. Sweden Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.9. Norway
    • 7.6.9.1. Key Country Dynamics
    • 7.6.9.2. Competitive Scenario
    • 7.6.9.3. Regulatory Framework
    • 7.6.9.4. Reimbursement scenario
    • 7.6.9.5. Norway Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Asia Pacific Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. Japan
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Japan Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. China
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. China Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.4. India
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. India Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. South Korea Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.6. Australia
    • 7.7.6.1. Key Country Dynamics
    • 7.7.6.2. Competitive Scenario
    • 7.7.6.3. Regulatory Framework
    • 7.7.6.4. Reimbursement scenario
    • 7.7.6.5. Australia Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.7. Thailand
    • 7.7.7.1. Key Country Dynamics
    • 7.7.7.2. Competitive Scenario
    • 7.7.7.3. Regulatory Framework
    • 7.7.7.4. Reimbursement scenario
    • 7.7.7.5. Thailand Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.8. Latin America
  • 7.8.1. Latin America Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.2. Brazil
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. Brazil Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.3. Mexico
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Mexico Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.4. Argentina
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory Framework
    • 7.8.4.4. Reimbursement scenario
    • 7.8.4.5. Argentina Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.9. Middle East & Africa
  • 7.9.1. Middle East & Africa Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.9.2. South Africa
    • 7.9.2.1. Key Country Dynamics
    • 7.9.2.2. Competitive Scenario
    • 7.9.2.3. Regulatory Framework
    • 7.9.2.4. Reimbursement scenario
    • 7.9.2.5. South Africa Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.9.3. Saudi Arabia
    • 7.9.3.1. Key Country Dynamics
    • 7.9.3.2. Competitive Scenario
    • 7.9.3.3. Regulatory Framework
    • 7.9.3.4. Reimbursement scenario
    • 7.9.3.5. Saudi Arabia Medical Imaging Market Estimates and Forecasts, 22021 - 2033 (USD Million)
  • 7.9.4. UAE
    • 7.9.4.1. Key Country Dynamics
    • 7.9.4.2. Competitive Scenario
    • 7.9.4.3. Regulatory Framework
    • 7.9.4.4. Reimbursement scenario
    • 7.9.4.5. UAE Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.9.5. Kuwait
    • 7.9.5.1. Key Country Dynamics
    • 7.9.5.2. Competitive Scenario
    • 7.9.5.3. Regulatory Framework
    • 7.9.5.4. Reimbursement scenario
    • 7.9.5.5. Kuwait Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Koninklijke Philips N.V.
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. GE Healthcare
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Siemens Healthcare
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Canon Medical Systems
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Mindray Medical International
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Esaote
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Hologic, Inc
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Samsung Medison Co.Ltd
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Koning Corporation
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Perkin Elmer Inc.
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives
  • 8.2.11. FUJIFILM VisualSonics Inc.
    • 8.2.11.1. Company overview
    • 8.2.11.2. Financial performance
    • 8.2.11.3. Product benchmarking
    • 8.2.11.4. Strategic initiatives
  • 8.2.12. Carestream Health
    • 8.2.12.1. Company overview
    • 8.2.12.2. Financial performance
    • 8.2.12.3. Product benchmarking
    • 8.2.12.4. Strategic initiatives
  • 8.2.13. Hitachi
    • 8.2.13.1. Company overview
    • 8.2.13.2. Financial performance
    • 8.2.13.3. Product benchmarking
    • 8.2.13.4. Strategic initiatives
  • 8.2.14. Konica Minolta
    • 8.2.14.1. Company overview
    • 8.2.14.2. Financial performance
    • 8.2.14.3. Product benchmarking
    • 8.2.14.4. Strategic initiatives
  • 8.2.15. Varex Imaging
    • 8.2.15.1. Company overview
    • 8.2.15.2. Financial performance
    • 8.2.15.3. Product benchmarking
    • 8.2.15.4. Strategic initiatives